PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact.
Issa N, Obagi S, Damiani G, Wang J, Bunick C. PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact. Journal Of Drugs In Dermatology 2025, 24: 631-633. PMID: 40465498, DOI: 10.36849/jdd.9089.Peer-Reviewed Original ResearchConceptsPhosphodiesterase-4 inhibitorPhosphodiesterase-4Cyclic adenosine monophosphateClinical impactContraindications to systemic therapyEffective suppression of inflammationInhibition of phosphodiesterase-4Minimal systemic side effectsChronic inflammatory skin diseaseSystemic side effectsInflammatory skin diseaseTherapeutic decision-makingSuppression of inflammationMessenger cyclic adenosine monophosphateClinically meaningful guidanceCombination regimensSystemic therapyRefractory casesTreatment landscapeTargeted therapyLichen planusSkin erythemaAtopic dermatitisSeborrheic dermatitisSide effects
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply